Put Options

22 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 23, 2023

BUY
$0.43 - $0.65 $4,687 - $7,085
10,900 Added 68.13%
26,900 $13,000
Q1 2023

May 15, 2023

BUY
$0.46 - $0.81 $7,360 - $12,960
16,000 New
16,000 $11,000
Q3 2022

Nov 14, 2022

BUY
$1.04 - $322.5 $46,488 - $14.4 Million
44,700 Added 266.07%
61,500 $122,000
Q2 2022

Aug 15, 2022

BUY
$0.41 - $1.24 $2,173 - $6,572
5,300 Added 46.09%
16,800 $21,000
Q1 2022

May 16, 2022

SELL
$0.62 - $1.17 $1,240 - $2,340
-2,000 Reduced 14.81%
11,500 $8,000
Q4 2021

Feb 14, 2022

BUY
$1.09 - $1.89 $14,715 - $25,515
13,500 New
13,500 $15,000
Q3 2021

Nov 12, 2021

SELL
$1.44 - $2.73 $24,048 - $45,591
-16,700 Closed
0 $0
Q2 2021

Aug 06, 2021

SELL
$2.63 - $3.67 $5,786 - $8,074
-2,200 Reduced 11.64%
16,700 $45,000
Q1 2021

May 14, 2021

SELL
$2.82 - $5.6 $25,380 - $50,400
-9,000 Reduced 32.26%
18,900 $64,000
Q4 2020

Feb 12, 2021

SELL
$2.09 - $3.09 $4,807 - $7,107
-2,300 Reduced 7.62%
27,900 $74,000
Q3 2020

Nov 13, 2020

SELL
$2.39 - $3.43 $19,598 - $28,126
-8,200 Reduced 21.35%
30,200 $78,000
Q2 2020

Aug 13, 2020

SELL
$2.2 - $3.71 $58,960 - $99,428
-26,800 Reduced 41.1%
38,400 $123,000
Q1 2020

May 11, 2020

SELL
$1.9 - $4.98 $38,570 - $101,094
-20,300 Reduced 23.74%
65,200 $166,000
Q4 2019

Feb 12, 2020

SELL
$3.95 - $5.35 $14,220 - $19,260
-3,600 Reduced 4.04%
85,500 $410,000
Q3 2019

Nov 14, 2019

SELL
$4.13 - $6.94 $41,713 - $70,094
-10,100 Reduced 10.18%
89,100 $376,000
Q2 2019

Aug 20, 2019

BUY
$3.98 - $6.2 $93,530 - $145,700
23,500 Added 31.04%
99,200 $578,000
Q1 2019

May 15, 2019

SELL
$2.0 - $4.4 $128,600 - $282,920
-64,300 Reduced 45.93%
75,700 $291,000
Q4 2018

Feb 14, 2019

BUY
$1.61 - $3.62 $225,400 - $506,800
140,000 New
140,000 $232,000
Q3 2018

Nov 14, 2018

SELL
$2.26 - $3.27 $263,968 - $381,936
-116,800 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$3.46 - $5.14 $75,774 - $112,566
21,900 Added 23.08%
116,800 $458,000
Q4 2017

Feb 14, 2018

BUY
$4.0 - $6.54 $79,200 - $129,492
19,800 Added 26.36%
94,900 $393,000
Q3 2017

Nov 15, 2017

BUY
$4.99 - $6.57 $374,749 - $493,407
75,100
75,100 $461,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $443M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.